Welcome to our dedicated page for Lifemd news (Ticker: LFMDP), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.
News for LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) is closely tied to developments at LifeMD, Inc., the issuer of this preferred security. LifeMD regularly publishes updates about its virtual primary care and pharmacy operations, financing activities, and corporate governance, all of which can be relevant to investors following LFMDP.
Company announcements describe LifeMD as a provider of virtual primary care services and pharmacy solutions, with telemedicine, laboratory access, and pharmacy services supporting treatment across more than 200 conditions. News items highlight growth in telehealth revenue, expansion into areas such as weight management, women’s health, mental and behavioral health, and cardiometabolic care initiatives, and the evolution of its virtual care platform.
Investors tracking LFMDP can expect news related to LifeMD’s clinical programs, including collaborations with pharmaceutical manufacturers. Recent releases discuss expanded collaboration with Novo Nordisk, access to Wegovy and Ozempic within LifeMD’s weight management program, and the addition of the Wegovy pill to its virtual obesity care offering. Other updates cover developments in women’s health programs, including the appointment of clinical advisors, and the scaling of men’s health and RexMD-branded services.
Corporate and financial news is also significant for LFMDP followers. LifeMD has issued press releases on quarterly financial results, changes in independent registered public accounting firms, the divestiture of its majority interest in WorkSimpli Software LLC to focus on virtual care and pharmacy, and the establishment of a revolving credit facility. The company has additionally announced quarterly cash dividends on the 8.875% Series A Cumulative Perpetual Preferred Stock.
By reviewing the LFMDP news feed, readers can monitor how LifeMD’s virtual care strategy, partnerships, financial decisions, and governance updates may influence the context in which this preferred stock operates. Regular news provides a consolidated view of operational milestones and capital structure developments that matter to preferred and common equity holders alike.
LifeMD, Inc. (NASDAQ: LFMD), a prominent telehealth provider, announced its participation in the 21st Annual Needham Virtual Healthcare Conference scheduled for April 11-14, 2022. The company will present on April 13 at 3:00 PM ET and will offer one-on-one meetings for investors. LifeMD provides a wide range of telehealth services across all 50 states, focusing on primary care, diagnostics, and specialized treatments. The company's goal is to enhance access to affordable healthcare through its technology platform and mail-order pharmacy network.
LifeMD, Inc. (NASDAQ: LFMD/LFMDP) has declared a cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock. This dividend will be payable on April 15, 2022, to shareholders on record as of April 5, 2022. The company leverages its telehealth platform to enhance healthcare access and affordability across the United States, catering to various health conditions. LifeMD remains committed to expanding its services and outreach within the telehealth sector.
On March 23, 2022, LifeMD, Inc. (NASDAQ: LFMD) launched NavaMD™, a clinically studied OTC skincare line designed for women, incorporating over 35 patents and proprietary enzyme technology, Aquabeautine XL®. This innovative product line includes a cleanser, serum, moisturizer, and eye cream, all dermatologist-tested and suitable for various skin types. LifeMD aims to enhance telehealth offerings while ensuring personalized skincare solutions. The company's strategy continues to focus on expanding proprietary products in dermatology, leveraging its telehealth platform and expert medical team.
LifeMD, Inc. (NASDAQ: LFMD) announced its participation in the KeyBanc Virtual Healthcare Conference on March 22-23, 2022. CFO Marc Benathen will present on March 22 at 3:45 PM EST. LifeMD is a telehealth company operating across 50 states, focusing on virtual primary care, diagnostics, and specialized treatments.
This participation highlights their commitment to enhancing healthcare access through innovative technology and a nationwide mail-order pharmacy network. For registration inquiries, please contact KeyBanc's sales representatives.
LifeMD, Inc. (NASDAQ: LFMD) reported a 149% increase in FY2021 revenue, totaling $92.9 million, with fourth quarter revenue reaching $27.4 million, up 113%. The fourth quarter Adjusted EPS improved 19% sequentially to $(0.29). The company achieved record gross margins of 81% and improved cash flow by 21% sequentially. With over $41 million in cash and no debt, FY2022 revenue guidance is between $142 million and $148 million, aiming for Adjusted EBITDA profitability by Q4 2022.
LifeMD, Inc. (NASDAQ: LFMD) announced it will release its financial results for the year ending December 31, 2021, on March 7, 2022, after market close. The company will hold a conference call at 4:30 PM ET to discuss these results and provide a corporate update. LifeMD is a growing telehealth company offering virtual care across 50 states, utilizing a proprietary tech platform and pharmacy network to enhance healthcare accessibility.
LifeMD announced the nationwide launch of its virtual primary care platform, providing 24/7 access to affordable healthcare across all 50 states. This platform enables patients to connect with top-quality doctors through a simple three-step process: completing a health questionnaire, a virtual consultation, and ongoing access to care. With significant investments in technology and strategic partnerships, LifeMD aims to enhance healthcare access and efficiency. Previously available in beta, the platform targets the 25% of U.S. adults lacking a primary care physician.
LifeMD, a prominent telehealth company, will participate in two key conferences: the SVB Leerink Global Healthcare Conference from February 16-18, 2022, and Citi’s Virtual Healthcare Conference on February 23-24, 2022. Interested parties can request one-on-one meetings at the SVB conference via a provided link. LifeMD offers accessible telehealth services across 50 states, focusing on various healthcare needs through its advanced technology platform and nationwide pharmacy network. For more information, visit LifeMD.com.
LifeMD, Inc. (NASDAQ: LFMD) anticipates FY2022 revenue between $142 million and $148 million, reflecting a robust year-over-year growth of 149% with a fourth quarter revenue of $27.4 million. The company aims to achieve Adjusted EBITDA profitability by Q4 2022. CEO Justin Schreiber highlighted increasing demand for telehealth services and the launch of LifeMD Virtual Primary Care. CFO Marc Benathen noted progress in reducing cash burn and maintaining liquidity to support growth initiatives.
LifeMD announced management participation at the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 15-17, 2022. Investors interested in one-on-one meetings can register here. LifeMD is a direct-to-patient telehealth provider offering virtual medical care and prescription delivery across the U.S.
FAQ
What is the current stock price of Lifemd (LFMDP)?
